Pfizer CEO Albert Bourla (L) and Moderna CEO Stéphane Bancel (Matthew Busch/Bloomberg via Getty Images; Nancy Lane/The Boston Herald via AP Images, Pool)
March 17, 2023 10:47 AM EDTUpdated 11:14 AM
People
Pharma

Pfiz­er's Bourla and Mod­er­na's Ban­cel saw com­pen­sa­tion bumps in 2022

Kyle LaHucik

Senior Reporter

More Big Phar­mas and hot­ly-watched biotechs have dis­closed the to­tal com­pen­sa­tion fig­ures for their ex­ec­u­tives, high­light­ing the pay pack­ages of Covid-19 be­he­moths, in­sulin mak­ers and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times